The CEOs of the six largest for-profit insurers have different perspectives on Medicare Advantage.
The Latest
A swirl of challenges is looming for Medicare recipients ahead of the annual enrollment period beginning Oct. 15.
Elevance Health is launching Mosaic Health, a primary care venture with private equity firm Clayton, Dubilier & Rice.
Two of the CEOs of the largest health insurance companies were Division 1 athletes. Four held roles at UnitedHealth Group.
In 2023, more than 61% of Ozempic prescriptions went to patients with commercial health insurance, and less than 10% of all semaglutide prescriptions went to Medicaid enrollees, according to a study published Aug. 2 in JAMA Health Forum.
Centene is the most likely to overturn a prior authorization denial decision when appealed, while Humana is the least likely, according to a KFF analysis.
The Medicare Advantage business is facing major challenges — government scrutiny is rising, CMS regulations and payments are tightening, the cost of care is rising and negative media coverage abounds.
Here are 11 updates on UnitedHealth Group and its subsidiaries that Becker's has reported since July 22:
Premera Blue Cross has named Talha Ashraf as executive vice president and CFO.
Several payers are scaling back their prior authorization requirements in an effort to ease administrative burdens on providers.